#pharmaceuticals
India's drug lifeline to Africa disrupted by Iran war
The fragile logistics corridor via Gulf states that connects African patients with critical Indian pharmaceuticals has been thrown into disarray with the Strait of Hormuz closed. India has often been called the "pharmacy of the Global South," and for African …
Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL
The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures A…
Inside the Irish factory at the centre of the global weight-loss revolution
Eli Lilly’s huge 50-hectare manufacturing hub in Kinsale has placed Ireland at the centre of the biggest shift in global medicine in decades
Generic Ozempic is now on Canadian shelves. Is it the same as the brand name version?
Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic. But will these generics be just as good, and how much will the cost come down?
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences - 724881 - 04/29/2026
In Vivo Bioavailability-Bioequivalence Studies – Clinical
AbbVie loses patent plea for Hep C drug
The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to affordable treatment for millions. The patent office refused the application after AbbVie failed to contest oppositions and…
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States
GUANGZHOU, China, May 18, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty division of Intas Pharmac…
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India
Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline is anticipated with the entry of smaller brands and a significant drop in raw material costs. The cost for a month's do…
When will cheaper generic Ozempic arrive? #health
Timeline for generic Ozempic in the U.S. Cheaper generic versions of Ozempic are moving through other markets first, but the United States timeline is still unclear based on the coverage provided. One report states that India already has a generic version , a…
Cheaper generic Ozempic is coming soon — but not for Americans
India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?
India-Japan seek to advance coop in critical minerals, semiconductors & ICT
India and Japan have strengthened economic ties. A key dialogue focused on industrial and technological cooperation. Five sectors were prioritised: critical minerals, semiconductors, ICT, clean energy, and pharmaceuticals. Both nations aim to build resilient …
Dr. Reddy’s to Launch Generic Ozempic in Canada Within Days
Dr Reddy’s Laboratories Ltd. plans to launch its version of generic Ozempic this month, filling a void in the Canadian market months after a key patent expiry and paving the way for cheaper access to the GLP-1 drugs.
Drugmakers must report safety data from launch date, not approval date: CDSCO
India's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be submitted from the actual market launch date. This change aims to strengthen patient safety monitoring. Previously, report…
'Will cooperate with Vietnam on critical minerals, rare earths, energy cooperation': PM Modi
India and Vietnam have significantly boosted their strategic ties. Prime Minister Narendra Modi announced new cooperation in critical minerals, rare earths, and energy security. Thirteen MoUs were signed, covering digital technologies, pharmaceuticals, touris…
India Inc to bet over $20.5 billion across key US sectors in major investment push
Indian firms are set to invest more than twenty billion dollars in the United States. This significant investment will span technology, pharmaceuticals, and manufacturing sectors. US Ambassador Sergio Gor highlighted these plans, emphasizing the strengthening…
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR
Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Biocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder and CEO of Bicara Therapeutics. She holds advanced degrees and has prior industry experience. Biocon is also undergoing…
Canada Just Got Generic Ozempic. Americans Shouldn’t Hold Their Breath
It'll probably take several years before generic semaglutide could arrive stateside.
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end...
India–New Zealand sign 'once-in-a-generation' FTA
India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tariff lines, aimed at boosting exports from sectors such as textiles, leather, pharmaceuticals and processed foods.